CytoDyn (OTC: CYDY) Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients: https://t.co/ISEMI14TQu
#biotech #stocks #stockstowatch